Use of medication during pregnancy
277 results
1 - 100
Use of medication during pregnancy 
Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy- Chronic diseases and pregnancy
- Antenatal clinics: care and examinations
- Medical treatments for idiopathic thrombocytopenic purpura during pregnancy: Cochrane systematic review
- Mental disorders during pregnancy
- Skin problems during pregnancy
Antiviral medication exposure safe in first trimester of pregnancy- Ondansetron use in pregnancy associated with small increased risk of oral clefts
- Fertility counselling
- Safety of nitrofurantoin during pregnancy
- SSRI use during pregnancy may increase risk of speech/language disorders in offspring
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome
- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Ambulatory versus conventional methods for monitoring blood pressure during pregnancy: Cochrane systematic review
- Pain management for medical abortion before 14 weeks’ gestation
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Prescription stimulant use during pregnancy is unlikely to harm offspring
- Perioperative pharmacological interventions for fetal immobilisation during fetal surgery and invasive procedures
- Zolpidem associated with adverse pregnancy outcomes
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy
- Antenatal cardiotocography for fetal assessment
- Trichuriasis
- Hypnosis for pain management during labour and childbirth
- Traveller's infection prophylaxis
- Pregnant substance abuser
- Pneumococcal vaccination during pregnancy for preventing infant infection
- Oxytocin antagonists for assisted reproduction
- Overweight in pregnancy
- Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour
- Mind‐body interventions during pregnancy for preventing or treating women's anxiety
- Prenatal exposure to pregabalin associated with major birth defects
- Imaging for the exclusion of pulmonary embolism in pregnancy
- Diagnosis and treatment of malaria
- Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Periconception antibiotics associated with birth defects
- Pharmacological interventions for generalised itching (not caused by systemic disease or skin lesions) in pregnancy
- First-trimester intranasal triamcinolone increases risk of respiratory system malformations
- Iodine supplementation for women during the preconception, pregnancy and postpartum period
- Similar risk of major malformations in infants of asthmatic women with alternate treatment regimens
- Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health
- Paternal use of valproate is not associated with adverse outcomes among offspring
- Planned caesarean section for women with a twin pregnancy
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Maternal prebiotics supplementation during pregnancy and lactation does not reduce infant allergic disease
- Trichinellosis
- Interventions for heartburn in pregnancy
- Psychosocial and psychological interventions for treating antenatal depression
- In utero SSRI associated with adverse perinatal events
- Antiretroviral interventions for preventing breast milk transmission of HIV
- Recurrent miscarriage
- Interventions for trichomoniasis in pregnancy
- Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression
- Aerobic exercise for women during pregnancy
- Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese: Cochrane systematic review
- Interventions for improving outcomes for pregnant women who have experienced genital cutting
- Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy
- Adverse effects of hypertension treatment during pregnancy
- Migraine
- Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews
- Striae atrophiae caused by inappropriate therapy for fungal infecion - Image
- Cycling during pregnancy reduced the rate of GDM in overweight and obese women
- Pre-exposure prophylaxis for HIV prevention does not improve pregnancy outcomes
- Pre‐ and postsurgical medical therapy for endometriosis surgery
- Risk of a venous thromboembolism during the postpartum period
- Gastro-oesophageal reflux disease
- Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
- Interventions for treating constipation in pregnancy
- Pregnancy complications can be identified using masked ultrasound sweeps